Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis

Part of paid clinical trials in Mobile, Alabama.

Sponsor
Abbott
Study ID
NCT00049751
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of the study is to evaluate safety by collecting serious adverse events in subjects with moderately to severely active rheumatoid arthritis who are unable to obtain etanercept and who have failed one or more prior disease-modifying antirheumatic drugs (DMARDs).

Key Dates

Start date
Sep 30, 2002
Status verified
Aug 2006

Study Design

Enrollment
3,000 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Change in disease activity score at visit week 12 as compared to baseline

Locations (54)

FacilityCityStateZIPSite coordinators
Thomas McGee, MDMobileAlabama--
Desert Valley MedicalApple ValleyCalifornia--
Kenneth Hsu, MD, Inc.BakersfieldCalifornia--
Rheumatology ClinicLos AngelesCalifornia--
Michael Harrington, MDNapaCalifornia--
Midori Jane Nishio, MDWalnut CreekCalifornia--
Naveen Raja, MDWhittierCalifornia--
Mountain RheumatologyDenverColorado--
Division of Rheumatic Diseases/University of CT Health CenterFarmingtonConnecticut--
New Haven Medical Group, PCNew HavenConnecticut--
Norman Gaylis, MDAventuraFlorida--
Mike Schweitz, MDWest Palm BeachFlorida--
Maurice McCarthy, MDWinter HavenFlorida--
Intermountain OrthopedicsBoiseIdaho--
Institute of Arthritis ResearchIdaho FallsIdaho--
Loyola University Medical CenterMaywoodIllinois--
West Suburban Health CareOak ParkIllinois--
OSF Medical Group -RheumatologyPeoriaIllinois--
Rockford Clinic, Clinical Research DepartmentRocktonIllinois--
Pain Therapy CenterSchaumburgIllinois--
Baton Rouge ClinicBaton RougeLouisiana--
Thomas Pressly, MDShreveportLouisiana--
Rheumatology AssociatesPortlandMaine--
Northampton Internal Medicine AssociationNorthamptonMassachusetts--
Fallon Clinic ResearchWest BoylstonMassachusetts--
John Howland, MDBay CityMichigan--
Freeman Health SystemsJoplinMissouri--
Peggy Schlesinger, MDMissoulaMontana--
NJ Associates in MedicineFair LawnNew Jersey--
Internal Medicine and Rheumatic DiseasesMillburnNew Jersey--
Placido Morano, MDBrooklynNew York--
NYU Hospital for Joint DiseaseNew YorkNew York--
Alan Kaell, MDPort Jefferson StationNew York--
Carolina Bone and Joint, PAMonroeNorth Carolina--
Gordon Senter, MD Rheumatology, PASalisburyNorth Carolina--
MedCenter One Health SystemsBismarckNorth Dakota--
University Hospital of ClevelandBeachwoodOhio--
Arthritis ClinicCantonOhio--
STAT Research, Inc.DaytonOhio--
Arthritis and Osteoporosis Clinic, LLCBendOregon--
Jel M. Depper, MDBendOregon--
Sanford and Roumm RheumatologyCamp HillPennsylvania--
Frederick Murphy, MDDuncansvillePennsylvania--
Rheumatology AssociatesNorristownPennsylvania--
Rheumatology Associates, Ltd.SellersvillePennsylvania--
Low Country Research CenterNorth CharlestonSouth Carolina--
Medical Specialists of NashvilleNashvilleTennessee--
Arthritis and Osteoporosis Clinical Research Center of Central TexasWacoTexas--
Center of Arthritis and Rheumatic Disease, PCChesapeakeVirginia--
Margaret Gradzka, MDFairfaxVirginia--
Metropolitan Clinical ResearchFalls ChurchVirginia--
Northern Virginia Center for ArthritisRestonVirginia--
Lewis-Gale ClinicSalemVirginia--
ROAD ClinicLakewoodWashington--

Find similar trials in Mobile, AL

By condition
Rheumatoid arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Thomas McGee, MD· Mobile, ALDesert Valley Medical· Apple Valley, CAKenneth Hsu, MD, Inc.· Bakersfield, CARheumatology Clinic· Los Angeles, CAMichael Harrington, MD· Napa, CAMidori Jane Nishio, MD· Walnut Creek, CA

Related Studies